Issued Patents All Time
Showing 25 most recent of 72 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12364692 | Topical naloxone compositions and methods for using the same | Jutaro Shudo, Jianye Wen, Russell Haynes, Asha Sunkara | 2025-07-22 |
| 12358942 | Crystalline 19-nor C3,3-disubstituted C21-n-pyrazolyl steroid | Paul S. Watson, John Gregory Reid, Jian Wang, James J. Doherty, Stephen Jay Kanes | 2025-07-15 |
| 11884696 | Crystalline 19-nor C3,3-disubstituted C21-n-pyrazolyl steroid | Paul S. Watson, John Gregory Reid, Jian Wang, James J. Doherty, Stephen Jay Kanes | 2024-01-30 |
| 11752107 | 5-hydroxytryptophan gastroretentive dosage forms | Jacob Pade Ramsoe Jacobsen, Wu Lin, Ching Sieu Tay | 2023-09-12 |
| 11426403 | Formulations of 4-methyl-5-(pyrazin-2-yl)-3H-1,2-dithiole-3-thione, and methods of making and using same | Anthony Chris Garland, Barbara-Jean Anne Bormann-Kennedy, Bomi Framroze, Michael Grass, Casey Keith JAGER +2 more | 2022-08-30 |
| 11266649 | Pharmaceutical formulations | Jingrong Xu, William Jones, Felicia Flicker | 2022-03-08 |
| 11236121 | Crystalline 19-nor C3,3-disubstituted C21-N-pyrazolyl steroid | Paul S. Watson, John Gregory Reid, Jian Wang, James J. Doherty, Stephen Jay Kanes | 2022-02-01 |
| 11185544 | Formulations of 4-methyl-5-(pyrazin-2-yl)-3H-l,2-dithiole-3-thione, taste-modified formulations, and methods of making and using same | Anthony Chris Garland, Barbara-Jean Anne Bormann-Kennedy, Bomi Framroze, Michael Grass, Casey Keith JAGER +3 more | 2021-11-30 |
| 10987342 | Methods and compositions for transdermal delivery of a non-sedative amount of dexmedetomidine | Adchara Pongpeerapat, Amit Jain, Jianye Wen, Jutaro Shudo | 2021-04-27 |
| 10874642 | Methods and compositions for treating attention deficit hyperactivity disorder, anxiety and insomnia using dexmedetomidine transdermal compositions | Adchara Pongpeerapat, Amit Jain, Jianye Wen, Jutaro Shudo | 2020-12-29 |
| 10772871 | Dexmedetomidine transdermal delivery devices and methods for using the same | Adchara Pongpeerapat, Amit Jain, Jianye Wen, Jutaro Shudo | 2020-09-15 |
| 10617655 | Topical sphingosine-1-phosphate receptor agonist formulations and methods of using the same | Adchara Pongpeerapat, Kensuke Murata | 2020-04-14 |
| 10434150 | Methods and pharmaceutical compositions for treating celiac disease and gluten intolerance | Matthew Siegel | 2019-10-08 |
| 10188616 | Topical sphingosine-1-phosphate receptor agonist formulations and methods of using the same | Adchara Pongpeerapat, Kensuke Murata | 2019-01-29 |
| 10022340 | Topical sphingosine-1-phosphate receptor agonist formulations and methods of using the same | Adchara Pongpeerapat, Kensuke Murata | 2018-07-17 |
| 9993531 | Formulation for oral administration of proteins | Matthew Siegel | 2018-06-12 |
| 9980903 | Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract | Jenny Louie-Helm, John W. Shell | 2018-05-29 |
| 9801816 | Gastric retentive dosage forms for extended release of acamprosate into the upper gastrointestinal tract | Cuiping Chen | 2017-10-31 |
| 9597338 | Shell-and-core dosage form approaching zero-order drug release | Jenny Louie-Helm, John N. Shell | 2017-03-21 |
| 9301934 | Gastric retentive dosage forms for extended release of acamprosate into the upper gastrointestinal tract | Cuiping Chen | 2016-04-05 |
| 9017667 | Dosage forms that facilitate rapid activation of barley protease zymogen | — | 2015-04-28 |
| 9000046 | Gastric retentive dosage forms for extended release of acamprosate into the upper gastrointestinal tract | Cuiping Chen | 2015-04-07 |
| 8980254 | Formulation for oral administration of proteins | Matthew Siegel | 2015-03-17 |
| 8945619 | Shell-and-core dosage form approaching zero-order drug release | Jenny Louie-Helm, Gloria M. Gusler, John N. Shell | 2015-02-03 |
| 8802157 | Methods of treatment using a gastric retained gabapentin dosage form | Sui Yuen Eddie Hou | 2014-08-12 |